This move is archived. Current quotes and coverage live on the stock page.
Follow CNVI
Conavi Medical Corp. is facing a notable decline, reflecting investor concerns about its recent performance.
Conavi Medical Corp. (CNVI.V) saw its stock price drop by 4.35% in the latest trading session, closing at CA$0.22. This decline raises questions about the company's current market position and future prospects.
Investor takeaway: Investors should monitor Conavi Medical's performance closely, especially in light of its recent operational updates and market movements.
Advertisement
Conavi Medical Corp.
CNVI.V
CNVI.V
Conavi Medical Corp.
WealthAwesomeMarket cap
$20.01M
52W high
$0.70
52W low
$0.14
1W change
-9.38%
Analyst Price Targets
Based on analyst covering CNVI · as of Sep 30, 2026
Wall Street analysts forecast CNVI stock price to rise 796.6% over the next 12 months.
Consensus
BullishBased on avg. target vs last close (formal rating unavailable for Canadian listings)
Avg. Target
C$1.30
+796.6% Upside
Previously C$1.00 on Sep 17, 2026
Current Price
C$0.14
Last close
Targets are snapshotted when they change. Unchanged figures keep their original date. Not financial advice.
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on CNVI's historical volatility
30-Day Vol
67.8%
Annualized
90-Day Vol
91.6%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$0.12
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$0.14 | C$0.11 – C$0.17 |
| 60 trading days | C$0.13 | C$0.09 – C$0.18 |
| 90 trading days | C$0.12 | C$0.08 – C$0.18 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
Advertisement
Conavi Medical Corp. down 4.35% in one day
The stock's recent decline reflects a market cap of CA$23.8 million, highlighting the volatility of this small-cap stock.
Bull case
Conavi Medical is working hard to secure FDA clearance for its Novasight Hybrid™ system, which could open doors for future growth and market expansion.
Bear case
The lack of recent positive news and the stock's downward trend may signal underlying issues that could shake investor confidence.
Market Reaction
Advertisement
The recent 4.35% drop in Conavi Medical's stock can be attributed to a lack of significant news that could boost investor confidence. With a market cap of CA$23.8 million, the stock remains vulnerable to fluctuations based on investor sentiment.
Future Outlook
Despite the current downturn, Conavi Medical's submission of its Novasight Hybrid™ system for FDA clearance may provide a pathway for recovery. Investors will need to keep an eye on upcoming developments that could impact the company's trajectory.
Investor Sentiment
The absence of recent positive updates has led to a cautious sentiment among investors. As the company prepares for potential market launches, attention will be on how effectively it can navigate regulatory hurdles and leverage its innovations.
Best next step
Keep exploring this topic
If you want to go deeper, these are the most useful follow-up pages and tools for this topic.
Broker comparison
Best trading platforms in Canada
Compare $0-commission brokers before you act on a ticker story.
Safe cash
Best GIC rates in Canada
If the story makes you want to de-risk, compare guaranteed rates next.
HISA roundup
Best high-interest savings accounts
Keep dry powder in a no-fee savings account instead of chequing.
TFSA room
Check TFSA contribution room
Shelter the next contribution before you buy.
Advertisement
Wealth Awesome
Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.
View Full Profile →✅ Reviewed by Certified Financial Professionals
This content has been reviewed by CFA® charterholders and Certified Financial Planners (CFP®) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.
Why these credentials matter: CFA® charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFP® professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.
⚠️ Professional Disclaimer
This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.
